Prices are falling for the popular obesity treatments Wegovy and Zepbound, but steady access to the drugs remains challenging ...

Market quiet, Nifty futures subdued, Asian markets lower. Analysts predict benefits for Indian contract manufacturers from ...

As the use of GLP-1 medications such as Ozempic, Wegovy and Mounjaro becomes more widespread for weight loss, a growing concern is the unintended loss of muscle mass that often accompanies rapid fat ...

GLP-1 drugs like Ozempic® and Zepbound® have gained significant attention for treating both diabetes and assisting with weight loss.

Migraines are one of the world's most common neurological conditions, impacting nearly 15% of people globally. Despite this ...

A current weight-loss and diabetes drug has become a surprise candidate for migraine treatment, with a new pilot study ...

Weight-loss supplements recommended by influencers on social mead are generally ineffective for weight loss, but do have some benefits.

Retirees looking for dividend growth stocks at a reasonable price have ample reasons to look outside of America, especially ...

Gov. Maura Healey signed the new fiscal year's $61 billion operating plan on Friday, marking the earliest the state has ...

GLP-1 weight loss patches are everywhere but do they actually work as these trendy patches promise Ozempic-like results ...

MariTide, a new drug from Amgen, helped some people with obesity lose up to 20% of their body weight. In a phase 2 trial, a new GLP-1 drug helped people lose up to 20% of their body weight over a year ...

Mr. Abraham used his fortune to donate to super PACS supporting Democrats and to efforts to bring peace to the Middle East.